Indeed, the same principle we developed of targeting an axis of the NF-κB pathway with cancer-restricted function, rather than NF-κB globally, could be similarly applied to also selectively inhibit NF-κB oncogenic functions beyond the suppression of cancer-cell apoptosis [200,201], such as functions in governing tumour-associated inflammation. Here, NFKB1 is linked to cancer.